Pfizer says an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19, indicating the company is on track later this month to file an emergency use application with U.S. regulators. This interim analysis, from an independent board, looked at 94 infections recorded so far in a study that has enrolled nearly 44K people in the U.S. and 5 other countries.